Europe Health Technology Assessment Associate Lead

About the Role

This position emphasizes a collaborative approach, engaging with regional access leaders to identify and fulfill evidence needs from HTA stakeholders across Europe. The role will involve working closely with diverse internal teams to collect and synthesize evidence for various EU HTA-related projects, including PICO surveys and data consolidation.

Key Responsibilities

• Play a pivotal role in shaping market access strategies and clinical development plans for Takeda's oncology portfolio, focusing specifically on evidence requirements pertinent to HTA and payer stakeholders in Europe and Canada.
• Co-lead the preparation and submission of EU Health Technology Assessment (HTA) documents, including Joint Clinical Assessments and Joint Scientific Consultations, ensuring adherence to established EU Joint HTA guidelines and practices.
• Promote Takeda's core values while fostering collaboration among cross-functional, global, regional, and local teams to enhance awareness and adherence to EU HTA evidence requirements.

Your Contributions

• Assist in developing high-quality HTA government submission dossiers for new oncology medicines, collaborating closely with the EUCAN Access Lead.
• Partner with global and EUCAN PVA leads to ensure timely mapping of HTA and payer evidence requirements for designated assets, integrating insights into global development plans and evidence generation strategies.
• Act as a key member of the Payer Value and Patient Access (PVPA) sub-team, representing the joint EU HTA archetype's evidence needs in various internal and external discussions.
• Co-lead Joint Scientific Consultations and EU JCA submission teams, working with regional, global, and local experts.
• Serve as the primary contact for JCA and JSC related evidence topics for priority assets, liaising with relevant internal partners and external stakeholders.
• Guide internal stakeholders on methodological requirements for compliance with EU HTA regulations, complementing their existing product knowledge.
• Stay informed on the latest EU HTA guidelines, methods, and processes, communicating relevant updates to internal teams.
• Analyze trends and relationships among national HTA/payer bodies and regulatory agencies, providing strategic insights that will influence joint HTA and reimbursement strategies.

Qualifications and Skills

Required:

• A minimum of a bachelor’s degree, with an advanced/graduate degree preferred (MSc, PhD, MPH, MPP, MBA).
• A minimum of 6 years of experience within the biopharmaceutical industry or healthcare consulting, including at least 4 years focused on market access, health economics, pricing, or related fields.
• Strong understanding of EU payer and HTA environments, including trends and reimbursement methodologies.
• Exceptional verbal and written communication skills, with a proven track record of influencing stakeholders and working within cross-functional teams.
• Experience in managing complex projects with multiple stakeholders effectively, even under pressure.
• Solid understanding of drug development processes and familiarity with global pharmaceutical cross-functional teams.
• Adept at navigating complexity and ambiguity, focusing on delivering optimal HTA submission results.
• Capability to articulate HTA strategies and convert evidence into impactful value messages for advocacy.
• Hands-on experience with health technology assessment tools, value materials, and evidence synthesis methods.

Preferred:

• Advanced/graduate degree in relevant fields.
• Health economics certifications or diplomas.
• Background in oncology.
• Previous experience in a regional or global role.
• Experience leading national HTA submissions or engaging with regulatory agencies.

Travel Requirements

Willingness to travel domestically and internationally up to 20% of the time.

Additional Information

• Experience in assessing evidence needs for major HTA/payer stakeholders from EU5 or Canada.
• Proven collaboration and communication skills, with the ability to excel in matrix environments.
• Strong internal stakeholder management capabilities with a solution-oriented mindset.
• Comprehensive understanding of the clinical development process.